August 2003

|
Volume 15 Issue 10
It failed to be approved for the “plain” indication when the Cutting Balloon Global Randomized Trial shows no benefit over the plain balloon in pre-stenting era. In this multicenter, randomized clinical trial, cutting balloon angioplasty (CBA) did no…
Prospective randomized trials of coronary stenting with the Palmaz-Schatz (PS) stent (Cordis Corporation, Miami, Florida) in stable angina1,2 or in acute myocardial infarction3,4 have shown a reduced incidence of cardiac events. However, the PS stent…
Intravascular stent implantation is the preferred treatment for native and post-operative branch pulmonary stenosis.1–4 The standard procedure for stent placement1 includes calibrated angiography, which has been regarded as the optimal calibration me…
The use of the antiplatelet agents ticlopidine and clopidogrel, in addition to aspirin, has been proven to reduce subacute stent thrombosis (SAT) rates to
With the first implants of stents in coronary arteries, the promise of predictable, stable, catheter-based revascularization became a reality. However, as with many new therapies, the treatment can give rise to new disorders. In the earliest series o…
“My views are fluid, and are subject to change as circumstances change.” Winston Churchill Most hospitals undertake an annual strategic planning process. Medical practices also plan, but less frequently. In fact, sometimes medical practices e…